Articles

The hedge-fund founder defends his investments in China as others start to warm up to those embattled stocks.

S&P cites megabank’s ‘business strength’ as well as its diversification

Verve Therapeutics shares dropped more than 30% early Tuesday after the company paused enrollment in a trial of its gene-editing treatment for heart disease.

The gap between our goals and reality has never been wider

Rivian Automotive Inc. said Tuesday it delivered 13,588 vehicles in the first quarter, beating the FactSet consensus for 13,000.

Oil services company Schlumberger Ltd. announced Tuesday an agreement to buy chemical and drilling technologies company ChampionX Corp. in an all-stock deal valued at about $7.8 billion.

An index tracking the strength of the U.S. dollar against a basket of rivals touched its highest level since mid-November on Tuesday, adding to the headwinds facing U.S. stocks.

UL Solutions Inc., a testing, inspection and certification company, launched its initial public offering on Tuesday with plans to issue 28 million shares priced at $26 to $29 each.

GE Aerospace and GE Vernova begin life Tuesday as two, separate stocks as they ring the opening bell on the New York Stock Exchange.

Tesla’s March sales of China-made EVs in the country were nearly flat from a year before.

Shares of health insurers providing Medicare Advantage plans were hit hard Tuesday, after the Centers for Medicare and Medicaid Services announced a payment rate that disappointed investors looking for a bigger increase.

“They have lived in the same house in New Jersey for 50 years and they don’t throw anything away.”